Healthcare and Pharmaceuticals
GLOBAL STEM CELL THERAPY MARKET was valued at USD 105.24 Million in the year 2017. Global Stem Cell Therapy market is further estimated to grow at a CAGR of 12.33% from 2018 to reach USD 211.39 Million by the year 2023. North America region holds the highest market share in 2017 and the market is also considered as the fastest growing market in the forecasted period. At a country level, the U.S. is projected to grow strongly in the coming years. The growth is attributed to the presence of key market players, growing awareness of the stem cell usage in the various application in disorders such as central nervous system disorders, cardiovascular diseases, neurodegenerative diseases, metabolic, eye, and immune system.
Osiris Therapeutics, Inc. (U.S.), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), MEDIPOST Co., Ltd. (South Korea), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) are some of the key players in the Global Stem Cell Therapy market. Organic growth techniques such as expanding global presence along with increasing research and development activities to address the changing demand of the healthcare industry were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.
Growing Awareness Related to the Therapeutic Potency and effectiveness for Infection Management
Growing Public-Private Investment models for the Expansion of the Stem Cell Therapies in the developed regions
Varied Regulatory Guidelines across regions pertaining to for new Product Development.
Government supportive regulations across regions for the use of stem cell in improving the disease management.
Low Awareness in emerging market due to the Technical Limitations
Stem Cell Therapy market on the basis of various application, the autologous stem cell therapy is further subcategorized into cardiovascular diseases, wounds, and injuries, gastrointestinal diseases. The allogeneic stem cell therapy segment is estimated to grow at the highest CAGR till 2023. This growth is attributed to the growing usage of the allogeneic stem cell therapy products along with its broad therapeutic uses.
Further, Stem Cell Therapy market when segmented on the basis of source type Bone Marrow and Adipose Tissue both hold substantial market share in 2017. The reason being a development of greater genome-based cell investigation methods.
Key Benefits for Stakeholders
Stem Cell Therapeutic Product Manufacturers, Distributors and Retailers
Research and Development companies
Healthcare service providers like hospitals, laboratories, diagnostic centers
Technology Standards Organizations, Forums, Alliances and Associations
Regulatory bodies, Stem Cell Associations and Organizations
Allogeneic Stem Cell Therapy Market, By Application
Wounds and Injuries
Acute Graft-Versus-Host Disease (AGVHD)
Autologous Stem Cell Therapy Market, By Application
Wounds and Injuries
By Cell Source
Adipose Tissue-Derived Mesenchymal Stem Cells
Bone Marrow-Derived Mesenchymal Stem Cells
Cord Blood/Embryonic Stem Cells
Wounds and Injuries
Key Market Players
Medipost Co., Ltd.
Anterogen Co., Ltd.
Pharmicell Co., Ltd.
Holostem Terapie Avanzate Srl
JCR Pharmaceuticals Co., Ltd.
Osiris Therapeutics, Inc.
RTI Surgical, Inc.
(A brief overview of another 13 companies is also provided)
Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –
Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
220.127.116.11. Key Data from Secondary Research
2.1.2. Primary Research
18.104.22.168. Key Data from Primary Research
22.214.171.124. Breakdowns of Primary Interviews
2.2. Market Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
3. Executive Summary
4. Market Overview
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Stem Cell Therapy Market, By Type
6.1 Allogeneic Stem Cell Therapy Market, By Application
6.1.1 Musculoskeletal Disorders
6.1.2 Wounds and Injuries
6.1.4 Acute Graft-Versus-Host Disease (AGVHD)
6.2 Autologous Stem Cell Therapy Market, By Application
6.2.1 Wounds and Injuries
6.2.2 Cardiovascular Diseases
6.2.3 Gastrointestinal Diseases
7. Stem Cell Therapy Market, By Cell Source
7.1 Adipose Tissue-Derived Mesenchymal Stem Cells
7.2 Bone Marrow-Derived Mesenchymal Stem Cells
7.3 Cord Blood/Embryonic Stem Cells
8. Stem Cell Therapy Market, By Component
8.1 Musculoskeletal Disorders
8.2 Wounds and Injuries
8.3 Cardiovascular Diseases
8.5 Gastrointestinal Diseases
9. Geographical Analysis
9.2. North America
9.4. Asia Pacific
9.4.1. South Korea
9.5.1. Latin America
9.5.2. Middle East and Africa
10. Company Profiles
(Business Overview, Financial Overview, Product write Up, Recent Developments)
10.1 Medipost Co., Ltd.
10.2 Anterogen Co., Ltd.
10.3 Pharmicell Co., Ltd.
10.4 Holostem Terapie Avanzate Srl
10.5 JCR Pharmaceuticals Co., Ltd.
10.6 Osiris Therapeutics, Inc.
10.7 Nuvasive, Inc.
10.8 RTI Surgical, Inc.
(A brief overview of 13 companies is also provided)
11. Competitive Analysis
11.2. Market Positioning of Key Players
11.3 Competitive Strategies Adopted by Leading Players
11.3.1. Investments & Expansions
11.3.2. New Product Launches
11.3.3. Mergers & Acquisitions
11.3.4. Agreements, Joint Ventures, and Partnerships
12.2. Available Customizations
12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)
No Content Available.